page 1 of 5
Please click on Next tab to advance through activity.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.
Release Date: August 30, 2019
Last Reviewed: August 29, 2019
Expiration Date: August 30, 2020
Time to Complete Activity: 0.5 hour
Arshad M. Khanani, MD, MA (chair)
Clinical Associate Professor
University of Nevada, Reno School of Medicine
Managing Partner, Director of Clinical Research, Director of Fellowship
Sierra Eye Associates
Nancy M. Holekamp, MD
Professor of Clinical Ophthalmology
Washington University School of Medicine
St Louis, MO
Director, Retina Service
Pepose Vision Institute
Carl D. Regillo, MD, FACS
The Retina Service of Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Partner, Mid Atlantic Retina
This activity is provided by Paradigm Medical Communications, LLC.
This activity has been designed to address the educational needs of retina specialists and comprehensive ophthalmologists. It may also be of benefit to other clinicians treating patients with neovascular age-related macular degeneration (nAMD).
Statement of Need
nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have been contingent on regular, ongoing treatment, typically with intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy. This activity will acquaint retina specialists and comprehensive ophthalmologists with new treatments and strategies that have the potential to reduce nAMD treatment burden while maintaining or enhancing the long-term visual outcomes and safety associated with conventional dosing protocols and treatments. This activity will also address diagnostic challenges related to nAMD that can have a significant impact on early diagnosis, treatment, and optimal visual outcomes.
Upon proper completion of this activity, participants should be better able to:
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 0.5 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Commercial Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Instructions for Participation
To receive a CME certificate of participation, participants must:
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
This certified CME activity is designed using HTML5 media controls.
For desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Technical Support: If you have any technical problems or playback issues, please email us at email@example.com.
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Arshad M. Khanani, MD, MA
Grant/Research Support: Allergan, Inc; Gemini Therapeutics, Inc; Genentech, Inc; Graybug Vision, Inc; Gyroscope Therapeutics; Kodiak Sciences; Novartis Pharmaceuticals Corporation; Opthea; Oxurion; Recens Medical; REGENXBIO Inc; Roche Pharmaceuticals
Retained Consultant: Alcon Pharma; Allergan, Inc; Genentech, Inc; Graybug Vision, Inc; Kodiak Sciences; Novartis Pharmaceuticals Corporation; Opthea; Oxurion; PolyPhotonix; Recens Medical; REGENXBIO Inc; Roche Pharmaceuticals
Speakers Bureau: Allergan, Inc; Genentech, Inc; Novartis Pharmaceuticals Corporation
Nancy M. Holekamp, MD
Consultant/Independent Contractor: Allergan, Inc; BioTime; Inc; Clearside Biomedical, Inc; Gemini Therapeutics, Inc; Genentech, Inc; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals, Inc; ViewPoint Therapeutics, Inc
Grant/Research Support: Alimera Sciences; Allergan, Inc; Gemini Therapeutics, Inc; Genentech, Inc; Gyroscope Therapeutics
Speaker’s Bureau: Alimera Sciences; Allergan, Inc; Genentech, Inc; Regeneron Pharmaceuticals, Inc; Spark Therapeutics
Stockholder: Katalyst Surgical, LLC
Carl D. Regillo, MD, FACS
Grant/Research Support: Adverum Biotechnologies; Allergan, Inc; Genentech, Inc; Kodiak Sciences; Novartis Pharmaceuticals Corporation
Retained Consultant: Adverum Biotechnologies; Allergan, Inc; Genentech, Inc; Kodiak Sciences; Novartis Pharmaceuticals Corporation
No financial relationships to disclose.
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Independent peer reviewer has no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME activity represents the views and opinions of the individual faculty members, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
If you have any questions or comments, please email us at firstname.lastname@example.org.
© 2019 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.